drugset / Trial / NCT00004880

Vaccine Therapy in Treating Patients With Advanced Kidney Cancer

NCT00004880

Phase 1 Completed 14 enrolled Jonsson Comprehensive Cancer Center
Treatment

Summary

RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients who have advanced kidney cancer.

Timeline

Start
1997-06
Primary completion
2001-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject dendritic cell vaccine therapy Vaccine Intravenous

Indications